Literature DB >> 21532030

Hypoxia: just say NO?

Jacqueline K Limberg1, William G Schrage.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532030      PMCID: PMC3098687          DOI: 10.1113/jphysiol.2011.209007

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  6 in total

1.  Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans.

Authors:  Rachel R Markwald; Brett S Kirby; Anne R Crecelius; Rick E Carlson; Wyatt F Voyles; Frank A Dinenno
Journal:  J Physiol       Date:  2011-02-21       Impact factor: 5.182

2.  Effects of regional phentolamine on hypoxic vasodilatation in healthy humans.

Authors:  C J Weisbrod; C T Minson; M J Joyner; J R Halliwill
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

3.  Hypertension causes premature aging of endothelial function in humans.

Authors:  S Taddei; A Virdis; P Mattei; L Ghiadoni; C B Fasolo; I Sudano; A Salvetti
Journal:  Hypertension       Date:  1997-03       Impact factor: 10.190

4.  Adenosine receptor antagonist and augmented vasodilation during hypoxic exercise.

Authors:  Darren P Casey; Brandon D Madery; Tasha L Pike; John H Eisenach; Niki M Dietz; Michael J Joyner; Brad W Wilkins
Journal:  J Appl Physiol (1985)       Date:  2009-08-06

5.  Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension.

Authors:  Adam G Goodwill; Milinda E James; Jefferson C Frisbee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

6.  Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies.

Authors:  Clare J Ray; Mark R Abbas; Andrew M Coney; Janice M Marshall
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.